12-122172724-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_001014336.2(IL31):āc.183C>Gā(p.Gly61Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.158 in 1,609,362 control chromosomes in the GnomAD database, including 21,681 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.14 ( 1780 hom., cov: 32)
Exomes š: 0.16 ( 19901 hom. )
Consequence
IL31
NM_001014336.2 synonymous
NM_001014336.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.28
Genes affected
IL31 (HGNC:19372): (interleukin 31) IL31, which is made principally by activated Th2-type T cells, interacts with a heterodimeric receptor consisting of IL31RA (MIM 609510) and OSMR (MIM 601743) that is constitutively expressed on epithelial cells and keratinocytes. IL31 may be involved in the promotion of allergic skin disorders and in regulating other allergic diseases, such as asthma (Dillon et al., 2004 [PubMed 15184896]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 12-122172724-G-C is Benign according to our data. Variant chr12-122172724-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 3109379.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-3.28 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.231 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL31 | NM_001014336.2 | c.183C>G | p.Gly61Gly | synonymous_variant | 3/3 | ENST00000377035.2 | NP_001014358.1 | |
LRRC43 | NM_152759.5 | c.-406+4942G>C | intron_variant | NP_689972.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL31 | ENST00000377035.2 | c.183C>G | p.Gly61Gly | synonymous_variant | 3/3 | 1 | NM_001014336.2 | ENSP00000366234.1 | ||
LRRC43 | ENST00000537729.5 | c.-406+4942G>C | intron_variant | 5 | ENSP00000438751.1 |
Frequencies
GnomAD3 genomes AF: 0.141 AC: 21369AN: 151956Hom.: 1774 Cov.: 32
GnomAD3 genomes
AF:
AC:
21369
AN:
151956
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.170 AC: 41354AN: 243396Hom.: 3916 AF XY: 0.168 AC XY: 22097AN XY: 131728
GnomAD3 exomes
AF:
AC:
41354
AN:
243396
Hom.:
AF XY:
AC XY:
22097
AN XY:
131728
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.160 AC: 233402AN: 1457288Hom.: 19901 Cov.: 32 AF XY: 0.161 AC XY: 116986AN XY: 724716
GnomAD4 exome
AF:
AC:
233402
AN:
1457288
Hom.:
Cov.:
32
AF XY:
AC XY:
116986
AN XY:
724716
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.141 AC: 21383AN: 152074Hom.: 1780 Cov.: 32 AF XY: 0.143 AC XY: 10621AN XY: 74316
GnomAD4 genome
AF:
AC:
21383
AN:
152074
Hom.:
Cov.:
32
AF XY:
AC XY:
10621
AN XY:
74316
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
562
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at